Literature DB >> 7557504

Visual acuities and scotomas after 3 weeks' levodopa administration in adult amblyopia.

I Gottlob1, S S Wizov, R D Reinecke.   

Abstract

BACKGROUND: Previous studies have shown that both a single dose of levodopa and a 1-week administration of levodopa improve visual functions in adult amblyopic patients. In the present study, we investigated the effect of increased dosage and duration of levodopa on amblyopes' visual functions.
METHODS: Visual acuity and visual fields were examined before and after 3 weeks of daily administration of levodopa/carbidopa as well as 1 month and 2 months after completion of drug therapy in a double masked-design.
RESULTS: A significant increase in visual acuities and a decrease in fixation point scotomas were found. Changes were of comparable dimension to those found after 1 week of levodopa administration. Improvement of visual functions persisted 2 months after the levodopa/carbidopa administration was completed.
CONCLUSION: The present study confirms previous findings of improvement in visual function in amblyopia after levodopa/carbidopa administration. However, increasing the dosage and the duration of levodopa did not enhance the effect in adults.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557504     DOI: 10.1007/bf00180943

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Scaling of visual acuity measurements.

Authors:  G Westheimer
Journal:  Arch Ophthalmol       Date:  1979-02

2.  [A new test (C-test) for quantitative examination of crowding with test results in amblyopic and ametropic patients (author's transl)].

Authors:  W Haase; A Hohmann
Journal:  Klin Monbl Augenheilkd       Date:  1982-03       Impact factor: 0.700

3.  Visual acuities and scotomas after one week levodopa administration in human amblyopia.

Authors:  I Gottlob; J Charlier; R D Reinecke
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-08       Impact factor: 4.799

4.  Levodopa/carbidopa for childhood amblyopia.

Authors:  L E Leguire; G L Rogers; D L Bremer; P D Walson; M L McGregor
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-10       Impact factor: 4.799

5.  Effect of levodopa on contrast sensitivity and scotomas in human amblyopia.

Authors:  I Gottlob; E Stangler-Zuschrott
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-04       Impact factor: 4.799

6.  Levodopa and childhood amblyopia.

Authors:  L E Leguire; G L Rogers; D L Bremer; P Walson; M Hadjiconstantinou-Neff
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1992 Sep-Oct       Impact factor: 1.402

  6 in total
  12 in total

1.  The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

Authors:  J T Flynn; G Woodruff; J R Thompson; F Hiscox; W Feuer; J Schiffman; A Corona; L K Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experience.

Authors:  Ishfaq Ahmad Sofi; Satish K Gupta; Anuradha Bharti; Tariq G Tantry
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

Review 3.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

4.  Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.

Authors:  Michael X Repka; Raymond T Kraker; Roy W Beck; C Scott Atkinson; Darron A Bacal; Don L Bremer; Patricia L Davis; Matthew D Gearinger; Stephen R Glaser; Darren L Hoover; Daniel M Laby; David G Morrison; David L Rogers; Nicholas A Sala; Donny W Suh; Maynard B Wheeler
Journal:  Arch Ophthalmol       Date:  2010-09

5.  Influences of levodopa on expression of N-methyl-D-aspartate receptor-1-subunit in the visual cortex of monocular deprivation rats.

Authors:  Xiao-Nan Sun; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

6.  A randomized trial of levodopa as treatment for residual amblyopia in older children.

Authors:  Michael X Repka; Raymond T Kraker; Trevano W Dean; Roy W Beck; R Michael Siatkowski; Jonathan M Holmes; Cynthia L Beauchamp; Richard P Golden; Aaron M Miller; Lisa C Verderber; David K Wallace
Journal:  Ophthalmology       Date:  2015-02-09       Impact factor: 12.079

7.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

9.  Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial.

Authors:  C Gail Summers; John E Connett; Ann M Holleschau; Jennifer L Anderson; Inge De Becker; Brian S McKay; Murray H Brilliant
Journal:  Clin Exp Ophthalmol       Date:  2014-05-05       Impact factor: 4.207

10.  Pharmacological enhancement of treatment for amblyopia.

Authors:  Mohammad A Rashad
Journal:  Clin Ophthalmol       Date:  2012-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.